The Prescription Patterns of Western and Chinese Medicine of Young Asthma Patients Using Taiwan National Health Insurance Claim Data
Date Issued
2014
Date
2014
Author(s)
Chang, Wan-Hsuan
Abstract
Objective:
To analyze the outpatient characteristics and prescription patterns of younger asthma patients’ of both Chinese and Western medicine.
Methods:
Cross- sectional study
Results:
There are tatal 10,241 younger asthma patients devided in 3 seeking behavior: using Western medicine only (98.31%), using Chinese medicine only (0.66%) and using both Western and Chinese medicine (1.03%).
The age devided in 4 groups: 0-3,4-7,8-11,12-15 years old, the 4-7 years old group having the most patients (4,783,46.70%).The 8-11 and 12-15 years old group has more percentage of using both Chinese and Western medicine and using Chinese medicine only (3%) compare to the 0-3 and 4-7 years old group(1%).
The younger asthma patients’ gender percentage of male is 60% and female is 40%. Most of patients seeking for doctors in pediatric clinics (70%) at Taipei (30%). The 4-7 and 8-11 years old asthma patients having more percentage (6%) in using Chinese medicine in Eastern part of Taiwan.
The percentage of younger asthma patients in ER and inpatient is about 30%, and the percentage of atopic dermatitis or allergic rhinitis co-diease is about 25%.
The total prescriptions of younger asthma patients are 28,517, 27,532 using Western medicine only(96.70%), 199 using Chinese medicine only(0.55%); 786 using both Western and Chinese medicine(2.75%). Among these prescriptions, 5,821 attending the Western medicine pay-for-performance program(20.90%); 41 attending the Chinese medicine pay-for-performance program(8.63%).
The prescription of inhaled type antiasthmatic medicine using in the Western medicine only group and both Western and Chinese medicine group are about 10%, the oral type are about 70%, and about 20% are both inhaled and oral type antiasthmatic medicine. The prescriptions of inhaled type antiasthmatic medicine using in the attending Western pay-for-performance group are about 13% but 5% in not attending group, the oral type antiasthmatic medicine using in the attending group are about 68% but 78% in not attending group, and using both inhaled and oral type antiasthmatic medicine are about 19% in attending group and 17% in not attending group.
The total prescriptions usually have 1 antiasthmatic medicine, the number 1 antiasthmatic medicine in using Western medicine only group are oral beta-2 agonists(20%), and leukotrienes ,oral beta-2 agonists and oral corticosteroids plus oral beta-2 agonist are both the number 1 antiasthmatic medicine using both Western and Chinese medicine group(11%). The number 1 antiasthmatic medicine in attending Western pay-for-performance group are leukotrienes(23%), but the number 1 antiasthmatic medicine in not attending group are oral beta-2 agonists.
The number 1 antiasthmatic Chinese medicine complex in using Chinese medicine only group are Xiao-Qing-Long Tang(30%) , and Ding-Tran-Tang are the number 1 antiasthmatic Chinese medicine complex in both using Chinese and Western medicine group.(20%). The number 1 antiasthmatic Chinese medicine complex in attending the Chinese pay-for-performance group are Suzi-Jiang-Qi-Tang(44%) and the Xiao-Qing-Long Tang in not attending group(24%).
Conclusions:
[鍵入文字]
viii
The total outpatient younger asthma patients are 10,241 in 2007, 4-7 years old male in Taiper clinics are the main groups about these patients.The patients senior than 8 years old using Chinese medicine more then the patients who younger than 8 years old.
The prescription patterns of these patients are usually prescribed one antiasthmatic medicine, and the oral beta-2 agonists are the number 1 medicine. The prescription patterns of these patients are usually prescribed one antiasthmatic Chinese medicine complex,the “shizheng” medicine (Xiao-Ching-Long Tang and Ding-Tran-Tang) are the number 1 antiasthmatic Chinese medicine complex in one prescription.
In attending Western pay-for-performance group’s prescriptions, the inhaled type of antiasthmatic medicine having more percentage than not attending group, and the number 1 antiasthmatic medicine are not the same.
In attending Chinese pay-for-performance group’s prescriptions, the number 1 antiasthmatic Chinese medicine complex are not the same compare with not attending group.
Subjects
氣喘
論質計酬
處方型態
氣喘西藥
氣喘中藥複方
Type
thesis
File(s)![Thumbnail Image]()
Loading...
Name
ntu-103-R99849041-1.pdf
Size
23.32 KB
Format
Adobe PDF
Checksum
(MD5):09f1eccda0d962f27a1696400f5ea69b